Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

299 recalls, newest first

Class II · Moderate risk

Pyridoxine HCL

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0041-2022
Class II · Moderate risk

Glutathione 200mg/Ml Mdv

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0038-2022
Class II · Moderate risk

Cyclosporine 2% Mct Oil Susp

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0035-2022
Class II · Moderate risk

Ascorbic Acid

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0032-2022
Class II · Moderate risk

Ascorbic Acid

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0031-2022
Class II · Moderate risk

Magnesium Chloride

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0029-2022
Class II · Moderate risk

Calcium Chloride

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0028-2022
Class II · Moderate risk

Fludarabine Phosphate for Injection

Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.

Terminated Sterility / contamination Custopharm, Inc. NDC 24201-237-01 D-0765-2021

Recalls by year